With outstanding fundamentals, including top-class universities and hospitals, a government cognizant of the benefits that a robust research-based biopharma industry brings, and straightforward business processes, Singapore has long been a hub for life science companies looking to penetrate the vast Asia-Pacific region. This exclusive new report deep dives into Singapore’s key attractions for international investors,…
See Full ReportCountry Reports
This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In terms of healthcare and life sciences, the island now serves as a…
See Full Report
This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In terms of healthcare and life sciences, the island now serves as a…
See Full Report